Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179335 · ClinicalTrials.gov registry record
Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults
A clinical trial, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- 45
- Enrollment target
NCT00179335 is a clinical trial that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 45 participants.
The verdict
NCT00179335 has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
HIV infected patients, aged \</= 35 years and aged \>/= 55 years, who are regularly taking either efavirenz (EFV) or lopinavir/ritonavir (Lop/r) as part of their antiretroviral regimen are being asked to spend 12 hours at the researchers' clinic (the ACS clinic at Jacobi Medical Center, Bronx, New York) for an intensive pharmacokinetic study in which 5 cc of blood will be drawn 9 times over a 12 hour period. Patients taking EFV will return for one additional blood draw the following day.
Interventions
- PROCEDURE Blood drawing to determine drug levels
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2003-08 |
| Est. Completion | 2006-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00179335
The ClinicalTrials.gov registry entry for NCT00179335 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood drawing to determine drug levels is the first listed.
NCT00179335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00179335 about?
NCT00179335 is a clinical study titled "Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults". HIV infected patients, aged \</= 35 years and aged \>/= 55 years, who are regularly taking either efavirenz (EFV) or lopinavir/ritonavir (Lop/r) as part of their antiretroviral regimen are being asked to spend 12 hours at the researchers' clinic (the ACS clinic at Jacobi Medical Center, Bronx, New Y...
What is the current status of trial NCT00179335?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2003-08. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00179335?
The interventions under investigation include: Blood drawing to determine drug levels (PROCEDURE).
Who is sponsoring clinical trial NCT00179335?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.